Treatments

Treatments

When Should Patients Ask About CAR T?

Danielle Brander, MD, Andrew Schorr

Treatments

How Clinical Trials and Education Are Refining CAR T

Danielle Brander, MD, Andrew Schorr

Treatments

Ibrutinib + Venetoclax Shows Promising Results in Clinical Trials

Pat Clune, Andrew Schorr

Treatments

Who Is a CAR-T Trial Right For?

Danielle Brander, MD, Andrew Schorr

Treatments

Activating T Cells to Target CLL

Danielle Brander, MD, Andrew Schorr

Treatments

Fixed Duration Therapy for CLL

Nicole Lamanna, MD, Andrew Schorr

Treatments

Clinical Trial Combination Therapies

Matthew S. Davids, MD, MMSc, Andrew Schorr

Treatments

Making CLL Treatment Decisions

Carol Preston, Philip Thompson, MB, BS, Nicole Lamanna, MD

Treatments

Navigating and Thriving Through CLL

Ian Flinn, MD, PhD, Esther Schorr, Andrew Schorr

Treatments

Promising Trials in Chronic Lymphocytic Leukemia

Nitin Jain, MD, Michele Nadeem-Baker

Treatments

Is Chemotherapy Still Used in CLL?

Michele Nadeem-Baker, Nitin Jain, MD

Treatments

Oral Treatment Regimens and Response for CLL

Carol Preston, Philip Thompson, MB, BS

Knowledge is power.

Subscribe to e-newsletter(s) to receive emerging research and community updates right to your inbox.

Subscribe